Mouse monoclonal [BB4] antibody to Interferon beta.
Spezifität
This antibody recognises human interferon beta (IFN Beta), a ~22 kDa cytokine with wide-ranging antiviral, antimicrobial and antitumor effects. Interferons also serve to activate macrophages, natural killer cells and the presentation of antigens to the immune system by the major histocompatibility complex. The production of interferon is induced in response to microbes and other cytokines. The interferons are widely used to treat a variety of diseases and IFNB in particular is used to treat relapsing-remitting multiple sclerosis. recognises glycosylated and non-glycosylated human IFNß and there is no cross-reactivity with human interferon alpha or human interferon gamma.
Anwendungen
WB, ELISA
Reaktivität
Human
Immunogen
Recombinant full length human IFN Beta, expressed in E.coli.
Wirt
Mouse
Klonalität
Monoclonal
Klon
BB4
Isotyp
IgG2a
Konjugat
Unconjugated
Reinigung
Protein G affinity chromatography of tissue culture supernatant.
Konzentration
1 mg/ml
Produktform
Liquid
Formulierung
Supplied in Phosphate Buffered Saline with <0.1% Sodium Azide.
Lagerung
Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.
Allgemeine Hinweise
Mouse anti Human IFN beta antibody, clone BB4 recognizes human interferon beta (IFN Beta), a ~22 kDa cytokine with wide-ranging antiviral, antimicrobial and antitumor effects. Interferons also serve to activate macrophages, natural killer cells and the presentation of antigens to the immune system by the major histocompatibility complex. The production of interferon is induced in response to microbes and other cytokines. The interferons are widely used to treat a variety of diseases and IFNB in particular is used to treat relapsing-remitting multiple sclerosis. Mouse anti Human IFN beta antibody, clone BB4 recognizes glycosylated and non-glycosylated human IFNß and there is no cross-reactivity with human interferon alpha or human interferon gamma.